ZEB1 and esophageal squamous cell carcinoma: Our data presented herein imply that ZEB1‐AS1 may be a vital regulator in proliferation and invasion of ESCC cells, and targeting ZEB1‐AS1 may be a novel strategy for therapy of patients with ESCC.